Mortality after cancer among patients with diabetes mellitus: Effect of diabetes duration and treatment: (Questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Currie CJ [letter]

Diabetologia

Volumn 57, Issue 9, 2014, Pages 2003-2004

  Ranc, Kristina ^a,b   Jørgensen, Marit E ^a   Friis, Søren ^c   Carstensen, Bendix ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cancer; Diabetes duration; Insulin; Mortality; Oral hypoglycaemic agent; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; INSULIN; ORAL ANTIDIABETIC AGENT;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; DEMOGRAPHY; DENMARK; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; LETTER; NEOPLASM; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; SURVIVAL; CANCER SURVIVAL; CANCER THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT DURATION; COMPLICATION; FEMALE; MALE; MORTALITY;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 84905564099     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3329-2     Document Type: Letter

References (4)

1. Ranc K, Jørgensen ME, Friis S, Carstensen B (2014) Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia 57:927-934
2. Holden SE, Bannister CA, Currie CJ (2014) Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Diabetologia 57. doi: 10.1007/s00125-014-3281-1
3. Carstensen B (2006) Demography and epidemiology: practical use of the Lexis diagram in the computer age. Or: who needs the Cox-model anyway? Technical Report 06.2. Department of Biostatistics, University of Copenhagen. Available from: http://biostat.ku.dk/reports/2006/rr-06-2.pdf
4. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766-1777